Clinical Trial Update: Red Blood Cell Distribution Width as a Marker of Contrast Induced Nephropathy in Patients With Coronary Intervention

View source ↗

Summary

This ClinicalTrials.gov entry provides an update on a study exploring whether red blood cell distribution width can serve as a biomarker for contrast-induced ne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy

Snippet

Sponsor: Assiut University | Conditions: Contrast-induced Nephropathy | Status: UNKNOWN